<VariationArchive VariationID="545250" VariationName="NC_000002.12:g.(?_148211972)_(148423169_?)del" VariationType="Deletion" Accession="VCV000545250" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2019-01-26" MostRecentSubmission="2019-01-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="535514" VariationID="545250">
      <GeneList>
        <Gene Symbol="LOC126806367" FullName="BRD4-independent group 4 enhancer GRCh37_chr2:149016781-149017980" GeneID="126806367" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q23.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="148259212" stop="148260411" display_start="148259212" display_stop="148260411" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="MBD5" FullName="methyl-CpG binding domain protein 5" GeneID="55777" HGNC_ID="HGNC:20444" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q23.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="148020927" stop="148516971" display_start="148020927" display_stop="148516971" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="148778579" stop="149271045" display_start="148778579" display_stop="149271045" Strand="+" />
          </Location>
          <OMIM>611472</OMIM>
          <Haploinsufficiency last_evaluated="2016-08-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MBD5">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2016-08-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MBD5">Little evidence for dosage pathogenicity</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000002.12:g.(?_148211972)_(148423169_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q23.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" innerStart="148211972" innerStop="148423169" display_start="148211972" display_stop="148423169" variantLength="211198" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.(?_148211972)_(148423169_?)del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.(?_148211972)_(148423169_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000002.12:g.(?_148211972)_(148423169_?)del AND Schizophrenia" Accession="RCV000754234" Version="1">
        <ClassifiedConditionList TraitSetID="6396">
          <ClassifiedCondition DB="MedGen" ID="C0036341">Schizophrenia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-03-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-03-20" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-01-26" MostRecentSubmission="2019-01-26">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">30208311</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6396" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3697" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Schizophrenia</ElementValue>
                <XRef ID="Schizophrenia/6442" DB="Genetic Alliance" />
                <XRef ID="HP:0100753" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0005090" DB="MONDO" />
                <XRef ID="58214004" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SCZD</ElementValue>
                <XRef Type="MIM" ID="181500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Schizophrenia is highly heritable, as shown by family, twin, and adoption studies. For example, for identical twins, if one twin develops schizophrenia, the other twin has about a 50% chance of also developing the disease. The risk of the general population developing the schizophrenia is about 0.3-0.7% worldwide. The search for “schizophrenia genes” has been elusive. Initial linkage studies looked at parts of the genome associated with schizophrenia, and many candidate genes were identified, including APOE, COMT, DAO, DRD1, DRD2, DRD4, DTNBP1, GABRB2, GRIN2B, HP, IL1B, MTHFR, PLXNA2, SLC6A4, TP53, and TPH1. However, some of these have later been questioned. Microdeletions and microduplications have been found to be three times more common in individuals with schizophrenia, compared to controls. Because these deletions and duplications are in genes that are overexpressed in pathways related to brain development, it is possible that the inheritance of multiple rare variants may contribute to the development of schizophrenia. Several genetic disorders feature schizophrenia as a clinical feature. The 22q11.2 Deletion Syndrome comprises many different syndromes, of which one of the most serious is DiGeorge syndrome. Children born with DiGeorge syndrome typically have heart defects, cleft palate, learning difficulties, and immune deficiency. Schizophrenia is a late manifestation, affecting around 30% of individuals. Microdeletions and duplications in chromosome 1, 2, 3, 7, 15 and 16 have also been associated with schizophrenia. In 2014, a genome-wide association study looked at the genomes of over 35,000 patients and 110,00 controls. The study identified 108 SNPs that were associated with schizophrenia, 83 of which had not been previously reported. As expected, many of these loci occurred in genes that are expressed in the brain. For example, the SNPs included a gene that encodes the dopamine D2 receptor, DRD2 (the target of antipsychotic drugs), and many genes involved in glutamine neurotransmitter pathways and synaptic plasticity (e.g., GRM3, GRIN2A, SRR, GRIA1). More surprisingly, however, associations were also enriched among genes expressed in tissues with important immune functions. In 2016, a study based on nearly 65,000 people investigated the association between schizophrenia and variation in the Major Histocompatibility Complex (MHC) locus—a region on chromosome 6 that is important for immune function. The study focused on the C4 gene (complement component 4) that exists as two distinct genes: C4A and C4B, which encode particularly structurally diverse alleles. The study found that the alleles which promoted greater expression of C4A in the brain were associated with a greater risk of schizophrenia. By using mice models, the study showed that C4 is involved in the elimination of synapses during brain maturation. In humans, “synaptic pruning” is most active during late adolescence, which coincides with the typical onset of symptoms of schizophrenia. It is therefore possible that the inheritance of specific C4A alleles could lead to “run away” synaptic pruning, increasing the risk of schizophrenia. Further research may even determine C4 as a potential therapeutic target.</Attribute>
                <XRef ID="NBK62008" DB="Medical Genetics Summaries" />
              </AttributeSet>
              <Citation Type="general" Abbrev="NICE, 2009">
                <ID Source="BookShelf">NBK11681</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2022">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0584dda8-bc3c-48fe-1a90-79608f78e8a0</URL>
                <CitationText>DailyMed Drug Label, Quetiapine, 2022</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="NICE, 2014">
                <ID Source="BookShelf">NBK555203</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/cg192</URL>
                <CitationText>UK NICE Clinical Guideline CG192, Antenatal and postnatal mental health: clinical management and service guidance, 2020</CitationText>
              </Citation>
              <XRef ID="C0036341" DB="MedGen" />
              <XRef ID="D012559" DB="MeSH" />
              <XRef ID="MONDO:0005090" DB="MONDO" />
              <XRef Type="MIM" ID="181500" DB="OMIM" />
              <XRef Type="primary" ID="HP:0100753" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1517486" SubmissionDate="2018-04-20" DateLastUpdated="2019-01-26" DateCreated="2019-01-26">
        <ClinVarSubmissionID localKey=":Chr.2_148211972_148423169_Deletion|OMIM:181500" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV000778037" DateUpdated="2019-01-26" DateCreated="2019-01-26" Type="SCV" Version="1" SubmitterName="Department of Psychiatry, Nagoya University" OrgID="504826" OrganizationCategory="laboratory" OrgAbbreviation="NAGOYAPSYCH" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-03-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">30208311</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG CNV Guidelines, 2011</Attribute>
          <Citation>
            <ID Source="PubMed">21681106</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Oligo array</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="2" innerStart="148211972" innerStop="148423169" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="181500" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">30208311</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30208311</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB3925077</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1517486" TraitType="Disease" MappingType="XRef" MappingValue="181500" MappingRef="OMIM">
        <MedGen CUI="C0036341" Name="Schizophrenia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

